000			01941 a2200541 4500
005			20250517094133.0
264		0	_c20171229
008			201712s 0 0 eng d
022			_a1949-2553
024	7		_a10.18632/oncotarget.9185 _2doi
040			_aNLM _beng _cNLM
100	1		_aZhao, Jianyun
245	0	0	_aInhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells. _h[electronic resource]
260			_bOncotarget _cJun 2016
300			_a34785-99 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBridged Bicyclo Compounds, Heterocyclic _xpharmacology
650	0	4	_aCell Line, Tumor
650	0	4	_aCheckpoint Kinase 1 _xantagonists & inhibitors
650	0	4	_aDNA Damage _xdrug effects
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aDrug Synergism
650	0	4	_aG2 Phase Cell Cycle Checkpoints _xdrug effects
650	0	4	_aHL-60 Cells
650	0	4	_aHumans
650	0	4	_aLeukemia, Myeloid, Acute _xdrug therapy
650	0	4	_aMitosis _xdrug effects
650	0	4	_aMyeloid Cell Leukemia Sequence 1 Protein _xmetabolism
650	0	4	_aPhenylurea Compounds _xpharmacology
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors
650	0	4	_aPyrazines _xpharmacology
650	0	4	_aSulfonamides _xpharmacology
650	0	4	_aTHP-1 Cells
650	0	4	_aU937 Cells
700	1		_aNiu, Xiaojia
700	1		_aLi, Xinyu
700	1		_aEdwards, Holly
700	1		_aWang, Guan
700	1		_aWang, Yue
700	1		_aTaub, Jeffrey W
700	1		_aLin, Hai
700	1		_aGe, Yubin
773	0		_tOncotarget _gvol. 7 _gno. 23 _gp. 34785-99
856	4	0	_uhttps://doi.org/10.18632/oncotarget.9185 _zAvailable from publisher's website
999			_c26007837 _d26007837